Dr. Reddy’s Laboratories informs about updates

05 Mar 2026 Evaluate

In reference to intimation dated December 12, 2025, wherein the company had informed regarding a GMP and a Pre-Approval Inspection (PAI) conducted by the United States Food & Drug Administration (USFDA) at its formulations manufacturing facility (FTO-SEZ PU01) in Srikakulam, Andhra Pradesh, Dr. Reddy’s Laboratories has informed that the Company has received the Establishment Inspection Report (EIR) on March 04, 2026. The USFDA has classified the inspection outcome as 'Voluntary Action Indicated (VAI)' and concluded that the inspection is officially closed under 21 CFR 20.64(d)(3).

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1254.65 -27.30 (-2.13%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×